Thursday, 6 February 2014

Brokerage cautious on Ranbaxy post Q4 show; stock down over 20% in 2014

Analysts have maintained their cautious stance on Ranbaxy Laboratories even though the drugmaker reported a drastic drop in net loss.



from Stocks-Markets-The Economic Times http://ift.tt/1kY8DVo

No comments:

Post a Comment